As of October 1, 2015, the U.S. healthcare system will undergo a significant change requiring that all healthcare providers and and all healthcare facilities start using ICD-10. ICD-10 is the 10th revision of the International Statistical ...
Prior authorizations ensure that our patients can get access to the medications they need while reducing administrative hassles for your practice. In our two-part blog series, we are giving you a "behind-the-scenes" look at what's new and what's ...
A “BEHIND-THE-SCENES” LOOK AT WHAT’S NEW AND NEXT IN THE WORLD OF PRIOR AUTHORIZATIONS...AND HOW PROVIDERS AND PATIENTS CAN BETTER MANAGE THIS PROCESS. There is no doubt that prior authorizations are becoming a more important strategy for payers, ...
Data breaches are in the headlines daily, and most issues are only those large enough to be newsworthy. From Target’s credit card breach in 2014, to the most recent hacking of data from millions of Anthem’s health plan members, consumers certainly ...
At Avella, it is both our privilege and responsibility to help improve patient health. Because of this, we are featuring the story of one of our incredible patients. As we all know, the journey through a serious disease is one for the patient, ...
Novartis announced this week that the US Food and Drug Administration has approved Jadenu™ (deferasirox) tablets. Jadenu is a new oral tablet for the treatment of chronic iron overload. Chronic iron overload can occur due to blood transfusions in ...
We are excited to announce the results of our latest patient satisfaction survey. More than 95% of Avella’s customers rate their experience with the specialty pharmacy as “excellent” or “very good” according to third-party validated data. Avella’s ...
A breakthrough treatment for hepatitis C genotype 1 is here. Avella is proud to fulfill HARVONI™ in treating hepatitis C patients. HARVONI™ is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV ...
Medication non-adherence is a serious, widespread issue that impacts clinical outcomes and contributes to rising healthcare costs. In fact, 20-30% of prescriptions written are never filled by patients and around half of all medications for chronic ...
Avella has once again been designated as one of Inc. Magazine’s 5,000 fastest growing companies in America, currently listed at #1,772 nationwide with a 3-year growth rate of 234%. Avella has been included in this select group of innovative ...
